ARMO BioSciences (ARMO) IPO Opens Up 65%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
ARMO BioSciences Announces Pricing of Initial Public Offering
January 25, 2018 9:09 PM ESTREDWOOD CITY, Calif., Jan. 25, 2018 /PRNewswire/ -- ARMO BioSciences, Inc. ("ARMO"), a late-stage immuno-oncology company, today announced the pricing of its initial public offering of 7,529,412 shares of its common stock at a price to the public of $17.00 per share for total gross proceeds of approximately $128.0 million. The shares are expected to begin trading on The Nasdaq Global Select Market on January 26, 2018 under the ticker symbol "ARMO." The offering is expected to close on January 30, 2018, subject to customary closing conditions.
In addition, ARMO has granted the underwriters a 30-day option to purchase up to an additional... More
